Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2016-11-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
And to evaluate patient acceptability and tolerability in order to determine the best way to perform hysteroscopy in an outpatient setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mini-hysteroscopy Versus Conventional Office Hysteroscopy in Nulliparous Patients Undergoing Office Hysteroscopy
NCT02823119
Hysteroscopic Surgery in Treatment of Intrauterine Abnormalities
NCT03265301
The Role of Hysterolaparoscopy in Infertile Patients With Normal Hysterosalpingography
NCT03106012
Pain and Hysteroscopy
NCT05316506
Comparison of Two Hysteroscopy Approaches
NCT00319410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Provision of outpatient based diagnostic and operative services are gaining prominence as a standard of cure but the experience of pain can be off-putting for patients having outpatient diagnostic hysteroscopy.
saline solution is an excellent alternative to carbon dioxide in women undergoing outpatient hysteroscopy, and there are fewer complications
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group(A)
2.7 mm rigid hysteroscopy.
office hysteroscopy 3.7
office hysteroscopy with a 3.7 -mm outer sheath
Group(B)
2.9 mm rigid hysteroscopy.
office hysteroscopy 4
office hysteroscopy with a4-mm outer sheath
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
office hysteroscopy 3.7
office hysteroscopy with a 3.7 -mm outer sheath
office hysteroscopy 4
office hysteroscopy with a4-mm outer sheath
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* female genital cancer
* Active pelvic infection
* Multipara
* patient not receiving misoprostol
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Essam Rashad Abdel-Hafeez Othman
Associate Professor, OB-GYN department-principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Essam Othman, MD
Role: PRINCIPAL_INVESTIGATOR
Assiut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Essam Othman
Assiut, Cairo, Egypt, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Essam Othman, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.